PT  - JOURNAL ARTICLE
AU  - Ghosh, Arup
AU  - Walia, Safal
AU  - Rattan, Roma
AU  - Kanampalliwar, Amol
AU  - Jha, Atimukta
AU  - Aggarwal, Shifu
AU  - Fatma, Sana
AU  - Das, Niyati
AU  - Chayani, Nirupama
AU  - Prasad, Punit
AU  - Raghav, Sunil K.
AU  - Parida, Ajay
TI  - Genomic profiles of vaccine breakthrough SARS-CoV-2 strains from Odisha, India
AID  - 10.1101/2021.08.16.21261912
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.08.16.21261912
4099  - http://medrxiv.org/content/early/2021/08/20/2021.08.16.21261912.short
4100  - http://medrxiv.org/content/early/2021/08/20/2021.08.16.21261912.full
AB  - Vaccine breakthrough infections pose a vast challenge in the eradication of the COVID pandemic situation. Emerging SARS-CoV-2 variants of concern infecting the immunized individuals indicate an ongoing battle between host immunity and natural selection of the pathogen. Our report sheds light on the prominent SARS-CoV-2 variations observed in the isolates from AZD1222/Covishield and BBV152/Covaxin vaccinated subjects.Competing Interest StatementThe authors have declared no competing interest.Funding StatementInstitute provided intramural grant to perform the study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study plan was approved by the Institute of Life Sciences Institutional Biosafety Committee (Ref no. V-122-MISC/2007-08/01) and the Institutional Human Ethical Committee (Ref no. 109/HEC/21). All necessary patient / participant consent has been obtained and the appropriate institutional forms have been archived.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesILS Intramural Grant.